BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 2, 2004
View Archived Issues
Beta adrenergic receptor targeted for treatment of male sexual dysfunction
Read More
Promising results of an HCV E1-based vaccine in hepatitis C patients
Read More
NPS Pharmaceuticals announces phase III clinical results for Preos in osteoporosis
Read More
Potent syncretic antimitotic agent by CombinatoRx
Read More
Novel bifunctional small molecule inhibitor to treat neurodegenerative diseases
Read More
Potassium channel openers for migraine and neuropathic pain from BMS
Read More
BMS-554216, a prodrug of BMS-204352, shows improved pharmacokinetics
Read More
MIV-150/Carraguard microbicide demonstrates encouraging preclinical results
Read More
Eisai to acquire Elan's Zonegran rights
Read More
Schering-Plough signs letter of intent for rights to garenoxacin
Read More
Axcan receives European marketing approval for Photobarr PDT
Read More
GenVec, PATH's MVI and NMRC expand malaria vaccine efforts
Read More
Guilford regains NAALADase inhibitor rights from Pfizer
Read More
Results from European phase III trial of Polyphenon E Ointment
Read More
GlaxoSmithKline and Theravance to form strategic alliance
Read More
Lupin to promote Zymar to U.S. pediatricians
Read More
Enrollment completed in second pivotal trial for Neurodex
Read More
Final statistical plan agreed for two pivotal Targretin trials
Read More
Intravenous Remodulin sNDA accepted for review
Read More
New phase I trial studies safety and immunogenicity of Vical's CMV vaccine
Read More
Kissei patent covers SGLT1 inhibitors for diabetes, obesity, etc.
Read More
Novel PARP inhibitors emerge from research at Kyorin
Read More
Cephalosporin derivatives with activity against MRSA disclosed
Read More
Ono discovers a novel series of PPAR inhibitors
Read More
Antiviral pyrazine derivatives designed by Toyama
Read More
Pfizer patent claims combinations of alpha-2-delta ligand/PDEV inhibitor for treatment of pain
Read More
Radioimmunotherapy with 131I-cG250 assessed in renal cell carcinoma
Read More
WX-G250 plus IFNalpha-2a reported safe and effective in renal cell carcinoma
Read More
OM-89 reduces the incidence of urinary tract infections in women
Read More
Ono claims use of ornoprostil to reduce diclofenac side effects, improve activity
Read More
Alfuzosin reduces need for surgery in acute urinary retention
Read More
CHIR-124, a novel small-molecule quinolone-based inhibitor of the CHK1 checkpoint
Read More
Ki-23057, a potent, metabolically stable inhibitor of FGFR2 characterized by Kirin
Read More
Pfizer presents data on PD-0325901, a more potent and pharmaceutically improved analogue of CI-1040
Read More